Business News
China just approved its first domestic anti-COVID pill, Azvudine, and is ready to produce 6.8 billion pills a year at half the price of Pfizer’s Paxlovid
[ad_1]
But Genuine Biotech’s Azvudine appears far less effective than Pfizer’s pill, too Read More
[ad_2]
Source link
